Trump won. But can he undo the damage the Democrats have inflicted on this nation? Under Biden, inflation soared 20%... Which could be the final blow for the American Dream - even with Trump in office.

Take these three steps today to protect your retirement from Biden's legacy >>>

NBSE Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 7.90%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

NeuBase Therapeutics Insider Trading History Chart

NeuBase Therapeutics Share Price & Price History

^$0.38

+0.30 (1.20%)

As of 09/20/2024 01:00 AM ET

Can Trump Make Housing Great Again?

From Behind the Markets | Ad

Take these three steps today to protect your retirement from Biden's legacy >>>

NeuBase Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/14/2023	Corp Symetryx	Major Shareholder	Sell	129,108	$1.44	$185,915.52	153,337
9/11/2023	Corp Symetryx	Major Shareholder	Sell	3,376	$1.44	$4,861.44	472,926
9/7/2023	Corp Symetryx	Major Shareholder	Sell	74,852	$1.80	$134,733.60	605,149
9/1/2023	Corp Symetryx	Major Shareholder	Buy	61,076	$0.98	$59,854.48	680,081
3/30/2022	William Roland Mann	COO	Buy	310	$38.40	$11,904.00
3/18/2022	Todd P Branning	CFO	Buy	500	$36.20	$18,100.00
3/16/2022	Todd P Branning	CFO	Buy	500	$32.40	$16,200.00
3/3/2022	Eric I. Richman	Director	Buy	65	$34.40	$2,236.00
3/1/2022	Eric I. Richman	Director	Buy	79	$31.60	$2,496.40

What Comes Next Could Be a Once-in-a-Lifetime Opportunity

From InvestorPlace | Ad

A wave of technological and financial transformation is reshaping the investment landscape. For those who understand the shifts ahead, this could be the foundation for long-term wealth creation. In this exclusive briefing, I'll show you exactly how to prepare for the challenges and opportunities ahead. You'll learn actionable strategies to protect your portfolio and position yourself for growth in the months and years to come.

Click here now to watch the full briefing and discover the steps to take today.

SEC Filings (Institutional Ownership Changes) for NeuBase Therapeutics (NASDAQ:NBSE)

12.37% of NeuBase Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

NeuBase Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/14/2023	Prelude Capital Management LLC	15,550	$29K	0.0%	-95.0%	0.920%
8/10/2023	Jacob Asset Management of New York LLC	15,655	$29K	0.0%	-95.0%	0.926%
8/1/2023	Carnegie Mellon University	46,970	$88K	0.1%	-95.0%	2.779%
7/28/2023	Decheng Capital Management III Cayman LLC	50,000	$92K	0.0%	-95.0%	2.959%
2/9/2023	CM Management LLC	350,000	$67K	0.1%	-22.2%	1.060%
11/14/2022	Worth Venture Partners LLC	212,035	$84K	0.1%	-17.4%	0.657%
11/4/2022	CM Management LLC	450,000	$0.18M	0.2%	+21.6%	1.395%
8/8/2022	CM Management LLC	370,000	$0.39M	0.4%	+13.8%	1.147%
7/29/2022	Perkins Capital Management Inc.	81,500	$86K	0.1%	+22.6%	0.253%
5/12/2022	AIGH Capital Management LLC	1,027,585	$1.93M	0.5%	+2.7%	3.136%
5/10/2022	Decheng Capital Management III Cayman LLC	1,000,000	$1.88M	0.6%	N/A	3.052%
5/9/2022	CM Management LLC	325,000	$0.61M	0.5%	+116.7%	0.992%
5/9/2022	Wealthsource Partners LLC	23,850	$45K	0.0%	N/A	0.073%
5/4/2022	Waldron Private Wealth LLC	79,620	$0.15M	0.0%	+296.4%	0.243%
4/20/2022	Perkins Capital Management Inc.	66,500	$0.13M	0.1%	+121.7%	0.203%
2/14/2022	Fifth Lane Capital LP	20,000	$56K	0.0%	N/A	0.061%
2/10/2022	Perkins Capital Management Inc.	30,000	$84K	0.1%	+42.9%	0.092%
2/10/2022	AIGH Capital Management LLC	1,000,285	$2.81M	0.9%	N/A	3.057%
2/9/2022	Jacob Asset Management of New York LLC	426,424	$1.20M	0.5%	+4.6%	1.303%
2/2/2022	CM Management LLC	150,000	$0.42M	0.3%	+100.0%	0.458%
11/16/2021	Two Sigma Advisers LP	178,821	$0.65M	0.0%	-12.4%	0.547%
11/15/2021	Marshall Wace LLP	50,310	$0.18M	0.0%	-63.1%	0.154%
11/15/2021	Tocqueville Asset Management L.P.	74,000	$0.27M	0.0%	+156.9%	0.226%
11/15/2021	GSA Capital Partners LLP	351,178	$1.27M	0.1%	+1.5%	1.073%
11/12/2021	Renaissance Technologies LLC	391,193	$1.41M	0.0%	-7.9%	1.196%
11/12/2021	Stonepine Capital Management LLC	109,742	$0.40M	0.2%	+253.2%	0.335%
11/12/2021	Jacob Asset Management of New York LLC	407,500	$1.47M	0.5%	+17.9%	1.246%
11/10/2021	Goldman Sachs Group Inc.	104,796	$0.38M	0.0%	-4.5%	0.320%
11/9/2021	BlackRock Inc.	81,716	$0.30M	0.0%	-6.0%	0.250%
11/8/2021	CM Management LLC	75,000	$0.27M	0.2%	N/A	0.229%
10/25/2021	Perkins Capital Management Inc.	21,000	$76K	0.0%	+41.9%	0.064%
8/25/2021	Marshall Wace LLP	136,421	$0.65M	0.0%	N/A	0.417%
8/17/2021	Walleye Capital LLC	17,212	$82K	0.0%	N/A	0.053%
8/17/2021	Millennium Management LLC	174,020	$0.83M	0.0%	+276.2%	0.532%
8/16/2021	Point72 Asset Management L.P.	1,250,000	$5.99M	0.0%	N/A	3.821%
8/16/2021	Cubist Systematic Strategies LLC	6,832	$33K	0.0%	N/A	0.021%
8/16/2021	Greenlight Capital Inc.	2,727,027	$13.06M	0.8%	+34.5%	8.335%
8/16/2021	First Trust Advisors LP	73,098	$0.35M	0.0%	+36.2%	0.223%
8/16/2021	Royal Bank of Canada	85,955	$0.41M	0.0%	+664.5%	0.263%
8/16/2021	Charles Schwab Investment Management Inc.	15,720	$76K	0.0%	-61.8%	0.048%
8/16/2021	State Street Corp	23,813	$0.11M	0.0%	-90.8%	0.073%
8/16/2021	Tibra Equities Europe Ltd	66,400	$0.32M	0.1%	N/A	0.203%
8/16/2021	Goldman Sachs Group Inc.	109,685	$0.53M	0.0%	+5.2%	0.335%
8/16/2021	Marshall Wace LLP	136,421	$0.65M	0.0%	N/A	0.417%
8/16/2021	Tocqueville Asset Management L.P.	28,800	$0.14M	0.0%	-38.1%	0.088%
8/13/2021	Renaissance Technologies LLC	424,851	$2.04M	0.0%	+116.9%	1.299%
8/13/2021	Northern Trust Corp	54,926	$0.26M	0.0%	-69.9%	0.168%
8/13/2021	Geode Capital Management LLC	233,856	$1.12M	0.0%	-25.9%	0.715%
8/13/2021	Vanguard Group Inc.	1,297,848	$6.22M	0.0%	+35.4%	3.967%
8/12/2021	Trexquant Investment LP	19,230	$92K	0.0%	N/A	0.059%
8/12/2021	Ergoteles LLC	76,652	$0.37M	0.0%	N/A	0.234%
8/11/2021	Bank of New York Mellon Corp	87,210	$0.42M	0.0%	-29.0%	0.267%
8/11/2021	Deutsche Bank AG	100,000	$0.48M	0.0%	+754.7%	0.306%
8/9/2021	Heritage Wealth Advisors	9,000	$63K	0.0%	+80.0%	0.028%
8/6/2021	Waldron Private Wealth LLC	20,088	$96K	0.0%	N/A	0.061%
8/5/2021	GSA Capital Partners LLP	346,151	$1.66M	0.2%	+465.9%	1.058%
7/27/2021	Heritage Wealth Advisors	9,000	$63K	0.0%	+80.0%	0.028%
5/18/2021	Millennium Management LLC	46,253	$0.34M	0.0%	+134.8%	0.200%
5/18/2021	D. E. Shaw & Co. Inc.	96,239	$0.71M	0.0%	+133.8%	0.415%
5/18/2021	Glenview Capital Management LLC	100,000	$0.74M	0.0%	N/A	0.431%
5/17/2021	Royal Bank of Canada	11,244	$83K	0.0%	+121.1%	0.049%
5/17/2021	Polar Asset Management Partners Inc.	634,618	$4.69M	0.0%	N/A	2.738%
5/17/2021	Nuveen Asset Management LLC	93,911	$0.69M	0.0%	-18.4%	0.405%
5/17/2021	Sphera Funds Management LTD.	31,900	$0.24M	0.0%	N/A	0.138%
5/17/2021	Goldman Sachs Group Inc.	104,235	$0.77M	0.0%	+16.6%	0.450%
5/13/2021	Renaissance Technologies LLC	195,878	$1.45M	0.0%	-53.6%	0.845%
5/12/2021	Northern Trust Corp	182,286	$1.35M	0.0%	-8.1%	0.786%
5/12/2021	Geode Capital Management LLC	315,525	$2.33M	0.0%	+24.3%	1.361%
5/12/2021	MYDA Advisors LLC	45,000	$0.33M	0.1%	N/A	0.194%
5/12/2021	JPMorgan Chase & Co.	51,222	$0.38M	0.0%	+5.4%	0.221%
5/10/2021	GSA Capital Partners LLP	61,163	$0.45M	0.1%	-49.6%	0.264%
5/10/2021	Oppenheimer & Co. Inc.	10,750	$79K	0.0%	N/A	0.046%
4/29/2021	Opal Wealth Advisors LLC	20,000	$0.15M	0.2%	N/A	0.086%
4/27/2021	Heritage Wealth Advisors	5,000	$37K	0.0%	-44.4%	0.022%
3/26/2021	Susquehanna International Group LLP	39,776	$0.28M	0.0%	N/A	0.172%
2/19/2021	JPMorgan Chase & Co.	48,581	$0.34M	0.0%	+370.4%	0.210%
2/16/2021	Nuveen Asset Management LLC	115,097	$0.81M	0.0%	-22.7%	0.497%
2/16/2021	Prelude Capital Management LLC	311,000	$2.17M	0.1%	N/A	1.342%
2/11/2021	Trexquant Investment LP	15,479	$0.11M	0.0%	N/A	0.067%
2/11/2021	Northern Trust Corp	198,246	$1.39M	0.0%	+1.8%	0.855%
2/10/2021	Rhumbline Advisers	16,595	$0.12M	0.0%	+8.0%	0.072%
2/10/2021	Renaissance Technologies LLC	422,378	$2.95M	0.0%	-24.1%	1.822%
2/10/2021	Group One Trading L.P.	3,860	$27K	0.0%	N/A	0.017%
2/9/2021	Wells Fargo & Company MN	32,827	$0.23M	0.0%	+8.9%	0.142%
2/9/2021	Bank of New York Mellon Corp	124,444	$0.87M	0.0%	+36.1%	0.537%
2/8/2021	New York State Common Retirement Fund	9,200	$64K	0.0%	-41.8%	0.040%
2/5/2021	BlackRock Inc.	929,233	$6.50M	0.0%	+2.5%	4.009%
2/4/2021	GSA Capital Partners LLP	121,389	$0.85M	0.1%	+25.7%	0.524%
2/2/2021	First Trust Advisors LP	49,228	$0.34M	0.0%	-4.3%	0.212%
2/1/2021	Heritage Wealth Advisors	9,000	$63K	0.0%	-18.2%	0.039%
11/16/2020	Greenlight Capital Inc.	2,027,027	$15.39M	1.3%	+6.5%	8.767%
11/13/2020	Morgan Stanley	11,672	$89K	0.0%	-22.3%	0.050%
11/13/2020	Oak Grove Capital LLC	19,975	$0.15M	0.1%	-28.6%	0.086%
11/13/2020	Charles Schwab Investment Management Inc.	41,158	$0.31M	0.0%	-5.3%	0.178%
11/12/2020	JPMorgan Chase & Co.	10,328	$78K	0.0%	-19.9%	0.045%
11/12/2020	Arrowstreet Capital Limited Partnership	54,700	$0.42M	0.0%	N/A	0.237%
11/10/2020	State Street Corp	277,645	$2.11M	0.0%	+11.6%	1.201%
11/6/2020	BlackRock Inc.	906,303	$6.88M	0.0%	-2.8%	3.920%
11/5/2020	First Trust Advisors LP	51,453	$0.39M	0.0%	N/A	0.223%

Data available starting January 2016

NeuBase Therapeutics, Inc., a preclinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as well as other genetic disorders, and cancer and oncology applications. Its pipeline includes NT0100 for Huntington's disease; NT0200 for myotonic dystrophy type 1; and NT0300 treatment targets the mutated KRAS gene. NeuBase Therapeutics, Inc. is headquartered in Pittsburgh, Pennsylvania.

Today's Range

Now: $0.38

$0.38

50 Day Range

MA: $0.38

$0.38

52 Week Range

Now: $0.38

$0.36

$4.80

Volume

N/A

Average Volume

N/A

Market Capitalization

$1.43 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.94

Who are the company insiders with the largest holdings of NeuBase Therapeutics?: NeuBase Therapeutics' top insider shareholders include:
Corp Symetryx (Major Shareholder)
Learn More about top insider investors at NeuBase Therapeutics.

Can Trump Make Housing Great Again?

From Behind the Markets | Ad

Take these three steps today to protect your retirement from Biden's legacy >>>

NBSE Insider Trading

NeuBase Therapeutics Insider Trading History Chart

NeuBase Therapeutics Share Price & Price History

NeuBase Therapeutics Insider Trading History

SEC Filings (Institutional Ownership Changes) for NeuBase Therapeutics (NASDAQ:NBSE)

Institutional Buying and Selling by Quarter

NeuBase Therapeutics Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of NeuBase Therapeutics?